Senior Scientist Stability jobs in United States
cer-icon
Apply on Employer Site
company-logo

Bristol Myers Squibb · 11 hours ago

Senior Scientist Stability

Bristol Myers Squibb is committed to transforming patients' lives through science. The Stability Senior Scientist is responsible for overseeing commercial drug substance and drug product stability programs, including developing product stability strategies and conducting stability data analysis.

BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
H1B Sponsor Likelynote

Responsibilities

Stability product strategy: determines/communicates stability requirements (e.g. Health Authority annual commitments, product/process change qualification batches, etc.) and assists with identifying production batches that meet these defined requirements for inclusion in the stability program
Perform change control impact assessments and document the assessments in change controls. Review and endorse change controls as required
Author change controls for changes to stability program/operations
Review/approve creation/modifications to Master Stability Protocols (MSP) and Study-Specific Protocols (SSP), batch-specific enrollment documentation, and LIMS stability studies
Perform stability data analysis/trending in support of data out-of-trend (OOT) analyses, regulatory submissions, Annual Product Quality Reviews (APQR), internal reports, etc
Authors stability sections of regulatory submissions (CTD dossiers for post-approval filings, annual reports, product renewals, health authority queries), APQR, and internal reports
Serve as stability subject-matter expert (SME) on project teams related to pre-market and post-approval changes
Develop and maintain expertise on the overall stability performance of biologic products, including maintaining a working knowledge of the attributes that impact product performance/stability profile
Serves as GBS representative for OOT/OOS investigations and other stability-related investigations/deviations. Complete stability impact assessments as needed
Expected to work with limited oversight from direct manager; but expected to identify and promptly escalate to management any critical issues related to stability program (e.g. potential impact to regulatory commitments, lab capacity, stability storage capacity)
Expected to critically evaluate situations and make decisions that require choosing between multiple options, or develop new options, to resolve moderately complex problems
Acts as an advisor/mentor to stability staff
Good organization skills and keen attention to detail

Qualification

Stability data analysisRegulatory submissionsChange control managementBiologics stability expertiseMaster Stability ProtocolsAttention to detailOrganizational skillsMentoring

Required

End-to-end oversight of commercial drug substance and drug product stability programs
Developing product stability strategy
Stability data analysis/trending
Preparation, review and approval of stability protocols, reports and regulatory filings
Determines/communicates stability requirements
Assists with identifying production batches that meet defined requirements for inclusion in the stability program
Perform change control impact assessments and document the assessments in change controls
Review and endorse change controls as required
Author change controls for changes to stability program/operations
Review/approve creation/modifications to Master Stability Protocols (MSP) and Study-Specific Protocols (SSP)
Perform stability data analysis/trending in support of data out-of-trend (OOT) analyses
Authors stability sections of regulatory submissions
Serve as stability subject-matter expert (SME) on project teams
Develop and maintain expertise on the overall stability performance of biologic products
Serves as GBS representative for OOT/OOS investigations
Complete stability impact assessments as needed
Work with limited oversight from direct manager
Identify and promptly escalate to management any critical issues related to stability program
Critically evaluate situations and make decisions that require choosing between multiple options
Acts as an advisor/mentor to stability staff
Good organization skills and keen attention to detail

Benefits

Health Coverage: Medical, pharmacy, dental, and vision care.
Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Based on eligibility, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.

Company

Bristol Myers Squibb

company-logo
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.

H1B Sponsorship

Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)

Funding

Current Stage
Public Company
Total Funding
$29.32B
Key Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B

Leadership Team

leader-logo
Charles Bancroft
CFO
linkedin
leader-logo
Cristian Massacesi
Executive Vice President, Chief Medical Officer and Head of Development
linkedin
Company data provided by crunchbase